David Miles Meredith, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Central Nervous System Neoplasms | 6 | 2022 | 869 | 1.990 |
Why?
|
Neural Tube | 4 | 2016 | 51 | 0.750 |
Why?
|
Retinal Neoplasms | 1 | 2021 | 143 | 0.740 |
Why?
|
Glioma | 7 | 2022 | 3299 | 0.710 |
Why?
|
Pathology, Surgical | 1 | 2020 | 149 | 0.710 |
Why?
|
Immunohistochemistry | 5 | 2021 | 11777 | 0.690 |
Why?
|
Retinoblastoma | 1 | 2021 | 317 | 0.690 |
Why?
|
Supratentorial Neoplasms | 1 | 2019 | 159 | 0.680 |
Why?
|
Chondroma | 1 | 2018 | 60 | 0.670 |
Why?
|
Transcription Factor RelA | 1 | 2019 | 295 | 0.670 |
Why?
|
Skull Neoplasms | 1 | 2018 | 175 | 0.620 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2022 | 477 | 0.610 |
Why?
|
Facial Bones | 1 | 2018 | 208 | 0.610 |
Why?
|
Fibroma | 1 | 2018 | 214 | 0.590 |
Why?
|
Ependymoma | 1 | 2019 | 327 | 0.590 |
Why?
|
Homeodomain Proteins | 2 | 2021 | 2459 | 0.480 |
Why?
|
Soft Tissue Neoplasms | 1 | 2021 | 1355 | 0.420 |
Why?
|
Lymphoma | 1 | 2020 | 1889 | 0.410 |
Why?
|
Trans-Activators | 1 | 2021 | 3069 | 0.400 |
Why?
|
NF-kappa B | 1 | 2019 | 2584 | 0.390 |
Why?
|
Transcription Factors | 8 | 2022 | 12073 | 0.360 |
Why?
|
Gene Expression Regulation, Developmental | 6 | 2016 | 3807 | 0.340 |
Why?
|
Bone Neoplasms | 1 | 2021 | 2594 | 0.340 |
Why?
|
Pancreas | 2 | 2013 | 1693 | 0.340 |
Why?
|
Brain Neoplasms | 7 | 2021 | 8805 | 0.320 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 4 | 2014 | 1152 | 0.280 |
Why?
|
Central Nervous System | 2 | 2022 | 1292 | 0.260 |
Why?
|
Chromatin | 3 | 2022 | 2741 | 0.260 |
Why?
|
Proteins | 1 | 2019 | 6166 | 0.250 |
Why?
|
Neurogenesis | 2 | 2014 | 833 | 0.250 |
Why?
|
Meningioma | 2 | 2022 | 1204 | 0.240 |
Why?
|
Meningeal Neoplasms | 2 | 2022 | 1221 | 0.230 |
Why?
|
Ribonuclease III | 2 | 2022 | 277 | 0.220 |
Why?
|
DEAD-box RNA Helicases | 2 | 2022 | 360 | 0.210 |
Why?
|
Immunoglobulin J Recombination Signal Sequence-Binding Protein | 2 | 2013 | 148 | 0.210 |
Why?
|
Transducin | 1 | 2020 | 48 | 0.210 |
Why?
|
Spinal Cord | 4 | 2016 | 1823 | 0.210 |
Why?
|
Retinoblastoma Binding Proteins | 1 | 2021 | 98 | 0.200 |
Why?
|
Lymphoma, Large-Cell, Anaplastic | 1 | 2022 | 165 | 0.200 |
Why?
|
Sarcoma | 2 | 2022 | 1878 | 0.190 |
Why?
|
Receptor, trkB | 1 | 2020 | 131 | 0.190 |
Why?
|
Oncogene Fusion | 1 | 2019 | 110 | 0.180 |
Why?
|
E1A-Associated p300 Protein | 1 | 2019 | 128 | 0.170 |
Why?
|
Transcription, Genetic | 3 | 2009 | 7952 | 0.170 |
Why?
|
Aneuploidy | 1 | 2021 | 480 | 0.170 |
Why?
|
Homeostasis | 1 | 2009 | 3344 | 0.170 |
Why?
|
Mitotic Index | 1 | 2018 | 173 | 0.170 |
Why?
|
Lymphoma, T-Cell | 1 | 2020 | 301 | 0.160 |
Why?
|
Chick Embryo | 4 | 2016 | 977 | 0.160 |
Why?
|
Granuloma, Plasma Cell | 1 | 2018 | 88 | 0.160 |
Why?
|
California | 1 | 2021 | 1395 | 0.160 |
Why?
|
Oncogene Proteins, Fusion | 3 | 2020 | 1615 | 0.150 |
Why?
|
Demyelinating Diseases | 1 | 2019 | 371 | 0.150 |
Why?
|
Astrocytoma | 1 | 2020 | 794 | 0.140 |
Why?
|
Prognosis | 6 | 2022 | 29226 | 0.140 |
Why?
|
Mouth Diseases | 1 | 2018 | 253 | 0.140 |
Why?
|
SOXB1 Transcription Factors | 2 | 2016 | 296 | 0.140 |
Why?
|
Receptor Protein-Tyrosine Kinases | 2 | 2022 | 1635 | 0.130 |
Why?
|
Adolescent | 10 | 2022 | 85139 | 0.130 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 1 | 2019 | 510 | 0.130 |
Why?
|
Child | 9 | 2022 | 74387 | 0.120 |
Why?
|
Humans | 30 | 2022 | 717237 | 0.120 |
Why?
|
Hepatocyte Nuclear Factor 3-beta | 1 | 2013 | 70 | 0.120 |
Why?
|
Genetic Markers | 1 | 2020 | 2692 | 0.120 |
Why?
|
Lymphoma, B-Cell | 1 | 2020 | 937 | 0.120 |
Why?
|
Mice, Transgenic | 5 | 2016 | 9927 | 0.120 |
Why?
|
Consensus Sequence | 1 | 2013 | 377 | 0.120 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2016 | 778 | 0.110 |
Why?
|
Pituitary Neoplasms | 1 | 2021 | 1295 | 0.110 |
Why?
|
Base Sequence | 6 | 2016 | 13317 | 0.110 |
Why?
|
Tumor Burden | 1 | 2018 | 1916 | 0.110 |
Why?
|
Central Nervous System Diseases | 1 | 2016 | 531 | 0.110 |
Why?
|
Child, Preschool | 5 | 2021 | 41221 | 0.110 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2021 | 1884 | 0.110 |
Why?
|
Parietal Lobe | 1 | 2016 | 820 | 0.100 |
Why?
|
Histones | 1 | 2020 | 2588 | 0.100 |
Why?
|
Neural Inhibition | 1 | 2014 | 592 | 0.100 |
Why?
|
Translocation, Genetic | 1 | 2015 | 1426 | 0.100 |
Why?
|
Young Adult | 7 | 2021 | 56247 | 0.090 |
Why?
|
Immunologic Factors | 1 | 2019 | 1575 | 0.090 |
Why?
|
Testicular Neoplasms | 1 | 2015 | 769 | 0.090 |
Why?
|
Cerebellum | 1 | 2016 | 1490 | 0.090 |
Why?
|
Vision Disorders | 1 | 2016 | 1038 | 0.090 |
Why?
|
Molecular Targeted Therapy | 1 | 2020 | 2865 | 0.080 |
Why?
|
Boston | 1 | 2021 | 9407 | 0.080 |
Why?
|
DNA Mismatch Repair | 2 | 2021 | 409 | 0.080 |
Why?
|
Repressor Proteins | 1 | 2019 | 3089 | 0.080 |
Why?
|
Waldenstrom Macroglobulinemia | 1 | 2016 | 1015 | 0.080 |
Why?
|
Male | 15 | 2022 | 351380 | 0.080 |
Why?
|
Glioblastoma | 1 | 2022 | 3357 | 0.080 |
Why?
|
Cost-Benefit Analysis | 1 | 2020 | 5268 | 0.080 |
Why?
|
Genetic Testing | 1 | 2020 | 3340 | 0.080 |
Why?
|
Software | 1 | 2021 | 4367 | 0.080 |
Why?
|
Feedback, Physiological | 1 | 2009 | 480 | 0.080 |
Why?
|
Mutation | 6 | 2022 | 29491 | 0.080 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2015 | 1308 | 0.070 |
Why?
|
Proto-Oncogene Proteins | 1 | 2019 | 4697 | 0.070 |
Why?
|
Genetic Loci | 1 | 2015 | 2614 | 0.070 |
Why?
|
Protein Binding | 3 | 2014 | 9665 | 0.070 |
Why?
|
Biopsy | 1 | 2018 | 6753 | 0.070 |
Why?
|
Nerve Tissue Proteins | 2 | 2009 | 4594 | 0.070 |
Why?
|
Gene Regulatory Networks | 1 | 2014 | 1730 | 0.070 |
Why?
|
Neurons | 3 | 2014 | 9441 | 0.070 |
Why?
|
Female | 13 | 2022 | 377909 | 0.070 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15271 | 0.070 |
Why?
|
Mice | 9 | 2020 | 81126 | 0.060 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2022 | 3698 | 0.060 |
Why?
|
Seizures | 1 | 2016 | 2592 | 0.060 |
Why?
|
Adult | 8 | 2022 | 212451 | 0.060 |
Why?
|
Neoplasm Proteins | 1 | 2015 | 3778 | 0.060 |
Why?
|
Zinc Fingers | 2 | 2016 | 598 | 0.060 |
Why?
|
E-Box Elements | 2 | 2014 | 19 | 0.060 |
Why?
|
Binding Sites | 4 | 2014 | 6295 | 0.050 |
Why?
|
Animals | 10 | 2022 | 170890 | 0.050 |
Why?
|
Cell Line | 2 | 2013 | 16693 | 0.050 |
Why?
|
Middle Aged | 6 | 2021 | 215041 | 0.050 |
Why?
|
Genome | 2 | 2021 | 1755 | 0.050 |
Why?
|
Genes, Neoplasm | 1 | 2021 | 392 | 0.050 |
Why?
|
DNA | 1 | 2013 | 7166 | 0.050 |
Why?
|
Pathology, Molecular | 1 | 2022 | 346 | 0.040 |
Why?
|
Infant | 4 | 2021 | 34574 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2022 | 8943 | 0.040 |
Why?
|
Palate, Hard | 1 | 2018 | 56 | 0.040 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2009 | 3010 | 0.040 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2022 | 622 | 0.040 |
Why?
|
Microsatellite Repeats | 1 | 2020 | 804 | 0.040 |
Why?
|
Methylation | 1 | 2020 | 1123 | 0.040 |
Why?
|
Mammals | 1 | 2022 | 944 | 0.040 |
Why?
|
Molecular Sequence Data | 4 | 2014 | 18738 | 0.040 |
Why?
|
Aged, 80 and over | 2 | 2020 | 58528 | 0.040 |
Why?
|
Lysine | 1 | 2020 | 1042 | 0.040 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2022 | 2661 | 0.040 |
Why?
|
Mutagenesis | 1 | 2020 | 1290 | 0.040 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2020 | 645 | 0.040 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2021 | 833 | 0.030 |
Why?
|
Documentation | 1 | 2021 | 870 | 0.030 |
Why?
|
Embryo, Mammalian | 2 | 2013 | 1766 | 0.030 |
Why?
|
Electroporation | 1 | 2016 | 253 | 0.030 |
Why?
|
Age of Onset | 1 | 2021 | 3333 | 0.030 |
Why?
|
Mice, Inbred C57BL | 2 | 2009 | 22929 | 0.030 |
Why?
|
Aged | 4 | 2020 | 162856 | 0.030 |
Why?
|
Retrospective Studies | 4 | 2022 | 72614 | 0.030 |
Why?
|
PAX2 Transcription Factor | 1 | 2013 | 77 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2018 | 1892 | 0.030 |
Why?
|
Glutamates | 1 | 2014 | 405 | 0.030 |
Why?
|
Gene Frequency | 1 | 2020 | 3714 | 0.030 |
Why?
|
Mediastinal Neoplasms | 1 | 2015 | 443 | 0.030 |
Why?
|
Chickens | 1 | 2014 | 881 | 0.030 |
Why?
|
Enhancer Elements, Genetic | 2 | 2009 | 1377 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2021 | 4312 | 0.030 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2020 | 3697 | 0.030 |
Why?
|
Membrane Proteins | 1 | 2009 | 8109 | 0.030 |
Why?
|
Treatment Outcome | 1 | 2018 | 62348 | 0.030 |
Why?
|
Cell Differentiation | 3 | 2016 | 11758 | 0.030 |
Why?
|
Cause of Death | 1 | 2021 | 3592 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2021 | 6778 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2013 | 914 | 0.020 |
Why?
|
Transcriptional Activation | 1 | 2016 | 1851 | 0.020 |
Why?
|
Body Patterning | 1 | 2014 | 652 | 0.020 |
Why?
|
Stem Cells | 2 | 2016 | 3597 | 0.020 |
Why?
|
5' Flanking Region | 1 | 2008 | 34 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2021 | 3100 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 2013 | 1988 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2013 | 2669 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2020 | 4916 | 0.020 |
Why?
|
DNA Primers | 1 | 2013 | 2999 | 0.020 |
Why?
|
Survival Analysis | 1 | 2021 | 10542 | 0.020 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2008 | 315 | 0.020 |
Why?
|
Pyrazoles | 1 | 2018 | 1976 | 0.020 |
Why?
|
Vertebrates | 1 | 2008 | 226 | 0.020 |
Why?
|
Dimerization | 1 | 2009 | 909 | 0.020 |
Why?
|
Promoter Regions, Genetic | 2 | 2009 | 6051 | 0.020 |
Why?
|
Genome, Human | 1 | 2020 | 4472 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2018 | 3433 | 0.020 |
Why?
|
Recurrence | 1 | 2018 | 8282 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2022 | 8013 | 0.020 |
Why?
|
Pyridines | 1 | 2018 | 2871 | 0.020 |
Why?
|
Genomics | 1 | 2021 | 5338 | 0.020 |
Why?
|
Retina | 1 | 2016 | 2651 | 0.020 |
Why?
|
Blotting, Western | 1 | 2013 | 5438 | 0.020 |
Why?
|
Disease Progression | 1 | 2021 | 13307 | 0.020 |
Why?
|
Conserved Sequence | 1 | 2008 | 1248 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2013 | 3615 | 0.020 |
Why?
|
Epithelium | 1 | 2008 | 1736 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2016 | 6929 | 0.010 |
Why?
|
Multiprotein Complexes | 1 | 2009 | 1172 | 0.010 |
Why?
|
Phenotype | 1 | 2020 | 16404 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2018 | 5495 | 0.010 |
Why?
|
Electroencephalography | 1 | 2016 | 5848 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2016 | 13274 | 0.010 |
Why?
|
Models, Genetic | 1 | 2008 | 3514 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2013 | 15258 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2013 | 20095 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2018 | 20434 | 0.010 |
Why?
|
Rats | 1 | 2008 | 25091 | 0.010 |
Why?
|
Signal Transduction | 1 | 2009 | 23996 | 0.000 |
Why?
|